How to safely switch from Ozempic to Mounjaro conversion chart

Key highlights

  • Mounjaro and Ozempic are both FDA-approved medications for Type 2 diabetes and are also used off-label for chronic weight management.
  • Mounjaro may be more effective than Ozempic for managing blood sugar and weight loss, with up to a 2.30% reduction in HbA1c and up to 20% body weight loss, compared to 1.86% and 10% with Ozempic.
  • Switching from Ozempic to Mounjaro requires a healthcare provider to adjust the dose carefully for safety and effectiveness.
  • Always consult your healthcare professional before changing medications to weigh the potential benefits and risks.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are both FDA-approved GLP-1 receptor agonists used to treat type 2 diabetes. They are also used off-label for weight loss.

It is important to know the correct dosage when switching between Ozempic and Mounjaro because they have different strengths and effects. Accurate conversion ensures the medication works properly for blood sugar control.

A conversion chart is a tool used by doctors to adjust doses accurately when switching medications, taking into account differences in potency, how long the drug works, and other factors that affect how the body processes the medication.

Patients transitioning between Ozempic and Mounjaro or healthcare providers adjusting treatment may need a conversion chart to ensure the correct dosage for effective management of blood sugar levels.

Learn about the key points of a conversion chart, understand what Mounjaro and Ozempic are, and follow a simple step-by-step guide to switch safely and effectively between these two medications.

What are Mounjaro and Ozempic?

Mounjaro is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that works similarly to Ozempic but also mimics a second hormone called GIP. Dual action helps better control blood sugar and promote weight loss, making it a strong option for managing type 2 diabetes.

Ozempic is a glucagon-like peptide 1 (GLP-1) receptor agonist that helps lower blood sugar levels by mimicking a hormone called GLP-1. This helps the body release insulin, reduce sugar production, and slow down digestion, leading to better blood sugar control and often significant weight loss.

The brand names Ozempic and Mounjaro are not approved by the FDA for weight loss, but similar medications made by the same companies with the same active ingredients are approved for weight loss under the names Wegovy and Zepbound respectively.

Both of these medications are used for glycemic control and given as weekly injections, but they work differently and have different dosages.

Understanding Mounjaro

  • Dosage: Injected under the skin once a week, with doses ranging from 2.5 mg to 15 mg weekly.
  • Efficacy: Mounjaro has shown strong a1c reduction and significant weight loss, often more effective than Ozempic and other appetite-reducing medications.
  • Side effects: Common side effects of Mounjaro include nausea, vomiting, and diarrhea. The combination of GLP-1 and GIP receptors may cause stronger side effects, especially when starting the treatment.
  • Mechanism of action: Mounjaro works by activating both GLP-1 and GIP receptors, enhancing insulin secretion, decreasing glucose production by the liver, reducing hunger and cravings, and promoting satiety leading to reduced food intake and weight loss.

In a study of over 2,500 adults with obesity, people who took 5 mg of Mounjaro for 72 weeks lost an average of 15% of their body weight. Higher doses led to even more weight loss.

Understanding Ozempic

  • Dosage: Ozempic is given as a weekly subcutaneous injection. It comes in 0.5 mg, 1 mg, and 2 mg weekly doses.
  • Efficacy: Ozempic can lower HbA1c levels and help with significant weight loss in people with type 2 diabetes.
  • Side effects: The most common side effects of Ozempic are nausea, vomiting, diarrhea, and stomach pain. Mild allergic reactions can also happen, but these symptoms usually disappear as the body gets used to the medication.
  • Mechanism of action: Ozempic boosts insulin release after meals, lowers glucagon, and slows digestion, helping control blood sugar after eating.

Clinical trials have shown that Ozempic provides cardiovascular benefits that reduce the risk of cardiovascular events such as stroke and heart attack in patients with type 2 diabetes

What is the difference between Ozempic and Mounjaro?

Ozempic, from Novo Nordisk, and Mounjaro from Eli Lilly, are both effective treatments for type 2 diabetes. However, they should not be used together or with any other GLP-1 or GIP receptor agonists.

Ozempic vs. Mounjaro

OzempicMounjaro
Active ingredients:SemaglutideTirzepatide
Mechanism of action:GLP-1 receptor agonist that boosts insulin release.GLP-1 and GIP receptor agonists boost insulin release, reduce hunger, and promote satiety.
Administration:Once a week subcutaneously (under the skin)Once a week subcutaneously (under the skin)
Efficacy:Lowering of HbA1c levels and weight loss.Greater reduction in HbA1c levels and more weight loss.
Dosage forms:Injectable (pre-filled pen)Injectable (pre-filled pen)
Available strengths:0.5 mg, 1 mg, 2 mg2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Dose:Starting dose: 0.25 mg
Maintenance dose: 0.5 mg-1 mg
Maximum dose: 2 mg
Starting dose: 2.5 mg
Maintenance dose: 2.5 mg-15 mg
Maximum dose: 15 mg
Blood sugar reduction (according to a 40-week study):Reduction in HbA1c by 1.86%Significant reduction in HbA1c up to 2.30%
Body weight reduction:10% of an individual’s total body weight.Up to 20% of an individual’s total body weight.
Side effects frequency:Nausea: 16%
Vomiting: 9.2%
Diarrhea: 9%
Stomach pain: 7%
Constipation: 5%
Nausea: 12%
Diarrhea: 12%
Vomiting: 9%
Stomach pain: 6%
Constipation: 6%
Cost:$1,326 per 1, 3 mL of 2 mg/3 mL pen$1,460 per 4, 0.5 mL of 5 mg/0.5 mL pen

Introducing compounded tirzepatide

Ozempic to Mounjaro conversion chart

The doses of Ozempic and Mounjaro are different, but both are started at a low dose and gradually increased. Mounjaro has a wider range of doses than Ozempic.

The charts below are not for direct conversions but provide general guidance for the typical doses of Mounjaro and Ozempic.

Ozempic to Mounjaro conversion chart

OzempicMounjaro
Starting dose:0.25 mg once weekly for 4 weeks2.5 mg once weekly for 4 weeks
Maintenance dose:0.5 mg to 1 mg once weekly5 mg to 12.5 mg once weekly
Maximum dose:2 mg once weekly15 mg once weekly

Mounjaro to Ozempic conversion chart

MounjaroOzempic
Starting dose:2.5 mg once weekly for 4 weeks0.25 mg once weekly for 4 weeks
Maintenance dose:5 mg to 12.5 mg once weekly0.5 mg to 1 mg once weekly
Maximum dose:15 mg once weekly2 mg once a week

Ozempic and Mounjaro equivalent doses

Ozempic doseEquivalent Mounjaro doseNotes
0.5 mg2.5 mgStarting dose for both medications is gradually increased.
1 mg5 mgTypical maintenance dose for both medications to keep blood sugar levels stable.
2 mg7.5 mgHigher doses for improved HbA1c reduction and increased weight loss.
-10 mg, 12.5 mg, 15 mgMounjaro provides higher doses for a more intense treatment, which are not available in Ozempic.

Your healthcare provider will look at your current dose and any side effects before deciding on the right dose for you.

A comparative chart was published in 2023 by the American Diabetes Association to help with drug shortages. This chart compares the medications based on their effects on blood sugar.

Why to switch from Ozempic to Mounjaro

People might switch to Ozempic from Mounjaro or vice versa because of side effects. Both medications can cause nausea, vomiting, diarrhea, indigestion, stomach pain, and constipation. If you have trouble with one, you might do better with the other.

Other reasons to switch include if:

  • You develop heart disease (Ozempic helps lower the risk of heart problems for people with type 2 diabetes and heart disease)
  • You want to lose more weight
  • Insurance or cost is an issue
  • Either of the medications is not available (drug shortages)
  • Your blood sugar is uncontrolled
  • You have an allergy to either of the medications

Can you take Ozempic and Mounjaro together?

No, you should not take Ozempic and Mounjaro together. Both medications work in similar ways to lower blood sugar, so using them at the same time could increase the risk of side effects. It is best to talk to your doctor to decide which one is right to decide which medication should be included in your treatment plan.

How to switch from Ozempic to Mounjaro

Switching from Ozempic to Mounjaro requires careful planning to ensure the change goes smoothly and that your blood sugar remains stable. Here’s a simple guide to help you switch safely.

  • Consult your doctor: Always talk to your doctor before making any changes to your medication. They will guide you on how to start Mounjaro safely and may suggest a gradual dose adjustment.
  • Watch for side effects: Both medications have similar side effects, but Mounjaro may cause stronger side effects due to its extra ingredient. You might experience stomach issues or low blood sugar symptoms like dizziness, shaking, or confusion. Contact your doctor if symptoms get worse.
  • Monitor blood sugar and weight: Keep track of your blood sugar levels and weight during the switch to ensure that the new medication is working properly. Report any significant changes to your doctor.

How to switch from Ozempic to Mounjaro

Time passed since the last dose of OzempicWhen to take the first dose of Mounjaro
1 dayIn 6 days
2 daysIn 5 days
3 daysIn 4 days
4 daysIn 3 days
5 daysIn 2 days
6 daysIn 1 day
7 or more daysToday

Speak with your healthcare provider

Before changing your diabetes medication, it is important to consult your doctor. They will assess your health, including your blood sugar levels (HbA1c levels), current weight, and other medical conditions, to analyze if switching to Mounjaro is right for you. Your doctor will also guide you on the right dose and how to manage any potential side effects if they occur. Make sure to ask about the cost and insurance coverage for Mounjaro.

Monitor blood sugar levels

After switching from Ozempic to Mounjaro, keep a close eye on your blood sugar levels, especially in the first few weeks. This helps to ensure the new medication is working well and not causing low blood sugar (hypoglycemia) or other issues. Keep track of your doses and report to your doctor if you notice any significant adverse effects.

Monitor side effects

Both Ozempic and Mounjaro can cause gastrointestinal side effects like nausea, vomiting, and diarrhea, especially when you start or change the dose. When switching to Mounjaro, these side effects may be stronger.

To reduce discomfort or prevent potential adverse events:

  • Start with the lower dose: Your doctor will likely begin with a small dose to minimize side effects.
  • Take it with food: This can help with nausea.
  • Drink plenty of water: Staying hydrated helps with stomach symptoms.

Talk to your doctor if side effects are severe or last for long. They might adjust your dose or suggest other treatments.

Consider lifestyle changes

Switching medications is only one part of managing type 2 diabetes. To get the most out of Mounjaro, make healthy lifestyle changes like eating a balanced diet, exercising regularly, and maintaining a healthy weight. These habits can help your medication work better and improve your overall health.

Introducing compounded tirzepatide

Bottom line

Transitioning from Ozempic to Mounjaro can lead to better blood sugar control and more weight loss, as Mounjaro has shown greater reductions in HbA1c and up to 20% weight loss.

Using a conversion chart helps doctors adjust the Mounjaro dose correctly based on your current Ozempic dosage for safe and effective treatment.

Consider making healthy lifestyle changes, like eating well and staying active, to enhance the effectiveness of your treatment.

Close monitoring of blood glucose levels and side effects is crucial during the switch, and working with your healthcare provider ensures a smooth transition and better diabetes management.

Share this page

Other articles on

    Also read

    Mounjaro vs. Ozempic

    Mounjaro vs. Ozempic: which is right for you?

    Did you know that over 38 million people have type 2 diabetes? As these numbers continue to rise, GLP-1 medications...

    Ozempic savings card

    Ozempic Savings Card: Eligibility, benefits and how to apply

    Ozempic (semaglutide) is a GLP-1 (glucagon-like peptide-1 receptor) agonist prescription medication approved by the...

    Does Aetna cover Ozempic?

    Does Aetna cover Ozempic?

    Ozempic is a brand-name prescription drug manufactured by step therapy are usually required. Does Aetna cover Ozemp...

    Does Ozempic need to be refrigerated

    Does Ozempic need to be refrigerated?

    Ozempic is a brand-name diabetes medication that needs to be stored in the refrigerator between 36°F to 46°F (2°...

    Does Mounjaro need to be refigerated?

    Does Mounjaro need to be refrigerated? Travel and storage guide

    Mounjaro (tirzepatide) is an FDA-approved drug prescribed for glycemic control in adults with type 2 diabetes melli...

    How much is Mounjaro without insurance

    How much is Mounjaro without insurance?

    Mounjaro (tirzepatide) is a GLP-1/GIP prescription injectable medication that was FDA-approved in 2022 for controll...

    Ozempic cost with insurance

    How much does Ozempic cost with insurance?

    Ozempic (semaglutide) is a popular brand-name drug used for treating type 2 diabetes and reducing the risk of major...

    How much weight can you lose on Mounjaro

    How much weight can you lose on Mounjaro?

    Mounjaro (tirzepatide) is an FDA-approved injectable medication for type 2 diabetes but is also used off-label for ...

    How much weight can you lose on Ozempic?

    How much weight can you lose on Ozempic?

    Ozempic (semaglutide) is a once-weekly injectable GLP-1 prescription medication approved for controlling blood suga...

    Sources (7)

    1. American Diabetes Association: Jaime P. Almandoz, Ildiko Lingvay, Javier Morales, Carlos Campos; Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance. Clin Diabetes 1 October 2020; 38 (4): 390–402. https://doi.org/10.2337/cd19-0100

    2. Wiley Online Library: Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance

    3. DailyMed: Label: MOUNJARO- tirzepatide injection, solution

    4. DailyMed: Label: OZEMPIC- semaglutide injection, solution

    5. American Diabetes Association: Heather P. Whitley, Jennifer M. Trujillo, Joshua J. Neumiller; Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clin Diabetes 1 July 2023; 41 (3): 467–473. https://doi.org/10.2337/cd23-0023

    6. Wiley Online Library: Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance

    7. National Library of Medicine: Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K; SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.

    The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.